$TSHA Cashflow Statement | Understand Stock

$TSHA

$4.25 +$0.24 (5.99%) Close

$TSHA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense
Stock-based compensation
Research and development license expense
Change in fair value of warrant liability
Issuance costs for pre-funded warrant liability
Non-cash loss on debt extinguishment
Non-cash change in fair value of term loan
Debt issuance costs expensed under the fair value option
Impairment of long-lived assets
Non-cash lease expense
Other
Changes in operating assets and liabilities:
Prepaid expenses and other assets
Accounts payable
Accrued expenses and other liabilities
Deferred revenue
Due to related party

Net cash used in operating activities
Cash flows from investing activities
Purchase of research and development license
Purchase of property, plant and equipment
Other
Net cash used in investing activities
Cash flows from financing activities
Proceeds from Term Loan, net
Proceeds from issuance of common stock and pre-funded warrants from underwritten public offering, net of underwriting discounts and sales commissions and other offering costs
Proceeds from issuance of common stock pursuant to at-the-market offering, net of sales commissions and other offering costs
Prepayment of 2023 Trinity term loan
Proceeds from 2025 Trinity term loan, net
Proceeds from issuance of common stock upon exercise of warrants
Debt issuance costs for term loan
Repayment of SVB term loan
Proceeds from Trinity term loan, net
Proceeds from issuance of common stock and pre-funded warrants from private placement, net of placement agent commissions and other offering costs
Proceeds from issuance of common stock from private placement
Public Offering
Offering to Astellas
At-the-Market Offering
Private Placement
Total proceeds from issuance of common stock from private placement

Payment of shelf registration costs
Proceeds from common stock issuances under ESPP
Proceeds from stock option exercises
Other
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at the beginning of the period
Cash, cash equivalents and restricted cash at the end of the period
Cash and cash equivalents
Restricted cash
Supplemental disclosure of cash flow information:
Cash paid for interest
Supplemental disclosure of noncash investing and financing activities:
Proceeds allocated to Success Fee liability
Right-of-use assets obtained in exchange for lease liabilities
Purchase of research and development license not yet paid
Build-to-suit lease liability
Non-cash impact of exercise of liability classified warrants
Allocation of proceeds to Success Fee liability
Recognition of asset retirement obligation
Issuance of warrants in connection with private placement
Property, plant and equipment in accounts payable and accrued expenses
Acquisition of property, plant and equipment funded by landlord
Offering costs not yet paid

Comments